With a market cap of $27.1 billion, DexCom, Inc. (DXCM) is a leading medical device company, specializing in continuous ...

DexCom ( DXCM -2.62%) is not a stock that investors should be rushing to sell. It has a few different opportunities to ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the ...

Biosensors that measure glucose are now available without a prescription. Wearing one was an emotional roller coaster ride.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an ...

Today, DexCom is the leading CGM company, with an estimated 40% market share. Importantly, CGM products are relatively nascent. DexCom generates nearly $4 billion in annual sales on a user base of ...

Maintaining stable glucose levels is essential for your overall health, whether or not you have diabetes. Here's ...

The Apple Watch integration with the Dexcom G7 continuous glucose monitor (CGM) has revolutionized diabetes management. With the best Apple Watch models, users can view real-time blood sugar data ...

Dexcom Inc. revealed data from several studies showing significant benefits of its continuous glucose monitoring technology on adults with type 2 diabetes who are not treated with insulin. In one ...

DexCom markets one of the world's most popular constant blood glucose monitors (CGM). These discreet devices adhere to the back of a person's arm and steadily measure their blood sugar ...

DexCom has helped revolutionize diabetes care with continuous glucose monitoring (CGM) devices. Patients wear a patch that continuously transmits blood sugar data to a device or smartphone.

About DexCom, Inc. DexCom ... If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider.